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Abstract. We have investigated the structure of the
small nuclear RNP (snRNP) Ul by combining EM of
complete and partially protein-deficient particles with
immunoelectron microscopy employing mAbs against
known components of the Ul snRNP It was found
that the two main protuberances of this particle can be
identified with the Ul-specific proteins A and 70K.
The 70K protuberance is the one lying closer to the 5'
terminus of the snRNA, as identified by its 5'-terminal
m3G cap. The round-shaped main body of Ul snRNP
U i small nuclear RNP (snRNP) is one of the major
snRNPs; the others are U2, U4/U6, and U5. All of
these snRNPs are essential factors in the splicing of
pre-mRNA; during the splicing process, several snRNPs
unite to form the so-called spliceosome particle (for review
see 24 and 41) . Mammalian Ul snRNP consists of a single
m3G-capped 165-nucleotide-long RNA molecule and at
least 11 proteins. Eight of these (B, B, D,, D2, D3, E, F,
and G) are common to all the snRNPs, while the proteins
70K, A, and C are contained only in the Ul particle (for re-
view see 23).
The main task of the snRNPs is the recognition and
removal of introns in the pre-RNA molecule. Ul snRNP
plays an essential part in the recognition of the 5' splice site,
as the 5' end of the RNA molecule of Ul base pairs with the
consensus sequence at the 5' splice site (38, 47) . The proteins
of Ul snRNP, especially protein C, are also involved in this
recognition (16), and the other two Ul-specific proteins A
and 70K are also essential for the splicing function of Ul
snRNP (12), although it is still unclear what role that they
play. Apart from the splice site, the Ul snRNP also appears
to recognize, directly or indirectly, a region of the intron in
the neighborhood of the branch point. This was first ob-
served in yeast (33, 36, 37) and has recently also been shown
for the mammalian system (2) .
The common proteins play an important part in the mor-
phogenesis of the Ul snRNP and the other m3G-capped
snRNPs. Their binding to the Ul RNA in the cytoplasm is
essential for the trimethylation of the 5'-terminal cap (25)
and for the transport of the Ul snRNPs into the cell nucleus
(9, 11) . It is still unknown to what extent the common pro-
teins are involved in the splicing reaction itself.
Experiments utilizing RNase digestion, chemical modi-
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represents its core RNP domain containing the com-
mon snRNP proteins. Functional implications of these
results are discussed . Our results may also point to the
physical basis for the production of autoantibodies
directed against specific groups of snRNP proteins.
The physical grouping of the common proteins (Sm
epitopes) and the specific proteins (RNP epitopes)
could result in one or the other being presented to the
immune system as is the case in patients suffering
from SLE or MCTD, respectively.
fication, and reconstitution assays in vivo and in vitro have
revealed much concerning the interaction between RNA and
proteins in the Ul snRNP The common proteins, some in
the form of a pre-formed complex, bind to a conserved se-
quence motifof the Ul snRNA. This motif, termed domain
A, is also contained in the snRNAs U2, U4, and U5; it con-
sists of a single-stranded region that is rich in U bases and
is flanked by two hairpin loops (stem/loops III and IV) and
occurs in the 3' half of Ul snRNA (5, 20) . The specific pro-
teins70K and A each possess a binding site on the Ul snRNA.
Protein 70K binds primarily to the 5' cap proximal hairpin
loop I and protein A to hairpin loop II (1, 22, 27, 28, 30, 34).
The binding site ofprotein C on Ul snRNP has not yet been
determined; it is probable that this protein does not bind
directly to the Ul RNA. In reconstitution experiments onoo-
cyte extracts from Xenopuslaelds, the binding ofproteins A,
70K, and C was found to be cooperative (13, 14) .
Interest in the RNP proteins of Ul is not restricted to their
cell and molecular biology, as they have important clinical
and immunological aspects. Patients suffering from inflam-
matory rheumatic disorders, such as systemic lupus erythem-
atosus (SLE) or mixed connective tissue disease (MCTD),
frequently produce antibodies against Ul snRNP proteins
(reviewed in 43). The presence of antibodies against the
common proteins, in particular B; B, D,, and D3 (the Sm
antigens) is regarded as diagnostic of SLE, and autoantibod-
ies against the Ul-specific proteins A, C, and especially 70K
(RNP antigens) are diagnostic of MCTD. The cause of the
production of the autoantibodies in such patients is largely
unexplained. A variety of immunological abnormalities, such
as B- and T-cell hyperreactivity, has been described for hu-
man SLE as well as for SLE-prone mice (45). However, it
is becoming increasingly clear that the production of anti-
839snRNP autoantibodies is antigen dependent (31, 43) . This
raises the perplexing question ofwhy autoantibodies are pro-
duced only against 70K, A, and C in the one condition
(MCTD) and against B'/B and D,-D3 in the other (SLE) . A
possible explanation is that the two antigen groups are dis-
tributed in a systematic, perhaps a polar, manner on the sur-
face of the Ul snRNP particle, which could lead to the one
or the other group being exposed to the immune system and
eliciting an immune response.
We have recently examined the Ul snRNP particle by EM
(17). Two morphologicallydistinct domain types were seen.
One was a round main body, N8 nm in diameter; the other
consisted of two protuberances. Here we describe attempts
to assign the Ul snRNP proteins to their morphological do-
mains. For this purpose we used two different methods. First
of all, we examined Ul snRNPs that were deficient in one
or more ofthe Ul-specific proteins 70K, A, and C. Secondly,
we made use of immunoelectron microscopy with mAbs to
define the position of the A and 70K proteins at the surface
of Ul snRNP Our results demonstrate thatthe two protuber-
ances contain the A and the 70K protein, respectively, and
that the round-shaped major domain represents the core
RNP structure of Ul snRNP containing all the common pro-
teins.
Materials and Methods
Preparation ofU1 snRNPs
Ul snRNPs lacking either (a) the C protein, (b) both proteins C and A, or
(c) all threespecific proteins, C, A, and 70K, were isolated fromHeLa cells
as described in detail elsewhere (1). In summary, nuclear extracts werepre-
pared according to Dignam et al. (8), and affinity chromatography with an
and-m3G column and competitive elution by m1G (3) was used to obtain
a mixture of snRNPs Ul to U6. Pure Ul snRNPs containing the full set of
specific proteins were isolated from this mixture by Mono Q chromatogra-
phy at4°C, whilechromatographyat elevated temperatures (20°C or37°C)
allowed the isolation of the protein-deficient Ul snRNPs (1) . The identities
ofthe snRNA and theproteinconstituents weredetermined by electrophore-
sis in 12% polyacrylamide gels as described by Bringmann et al. (6).
Chemical Cross-linkingofUI snRNPs
U1 snRNPs were purified in cross-linking buffer (20 mM triethanolamine
at pH 8.5, 300 mM KCI, 1.5 mM MgC12) by 5-20% glycerol gradient cen-
trifugation. Pooled fractions containing Ul snRNP (ti140 Wg protein per
ml) were cross-linked with dithio(bis[succinintidyl]) propionate (DSP) by
the following method, which follows Lamont and Fairbanks (21) and
Walleczek et al. (46). A solution of DSP (Sigma Chemical Co., St. Louis,
MO), 18 mM in DMSO was added slowly to the Ul snRNPs until the
desired final DSP concentration (60 pM unless otherwise stated) was
reached. After incubation at 0°C for 30 min, the reaction was terminated
by the addition of glycinamide hydrochloride (3 M, pH 4.0, to give a final
concentration of 50 mM) and a further incubation at 37°C for 40 min.
ImmunocomplexFormation
Immunocomplexes were prepared with IgG purified from preparations of
three mAbs with respective specificities for the A protein, the 70K protein,
and the m3G cap. The antibodies specific for A protein (DS) and for m3G
(1120) have been described previously (3,32). The 70K specific mAb H111
was purified from the supernatant ofthe hybridoma cell line Hl 11, derived
originally from a C57B1/6 mouse immunized with HeLa Ul snRNPs
(baser, A., R. Reuter, and R. Lührmann, unpublished results). The anti-
bodies were incubated with Ul snRNPs overnight at 4°C; the Ui snRNPs
used were either complete or else deficient in C or A protein. Both DSP-
cross-linked U1 snRNPs and non-cross-linked Ul snRNPs were used. In a
further experiment, the Hll l antibody was preincubated (1 h, 4°C) with the
pEE71 fusion protein before Ul snRNPs were added. This fusion protein,
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expressed in E. colt, contains the 33-kD NH2-terminal part of the 70K
protein fused to ß-galactosidase (Hornig, H., K. Bark, A. Heyer, and R.
Lührmann, unpublished observations).
Gradient Centrifugation
Immunocomplexes were separated fromunreacted U1 snRNPs and antibod-
ies by sucrose-gradient centrifugation (6-20% sucrose in cross-linking
buffer) in a Beckmad TLS55 rotor for 6 hat 50,000 rpm and 4°C. Gradients
were fractionated from the bottom up, and aliquots of each fraction were
analyzed fortheir snRNP and IgG content by microtitre ELISAas described
previously (17). In summary, the cavities were coated with the sample and
then saturated with BSA. Theamount ofUl snRNP in the samples was then
determinedby reaction with ahuman anti-RNP serum followed by detection
of the bound serum antibody complexes by an anti-(human IgG) antibody
conjugated with phosphatase (Sigma Chemical Co.). The amount of mouse
mAb in the samples was determined on a second ELISA plate by using a
phosphatase-conjugated anti-(mouse IgG) antibody (Paesel).
EM
Negative staining with 2.5% uranyl formate was carried out by the double
carbonfilm method as described byKastnerand Liihrmann (17). The prepa-
rations were examined under a Zeiss EM109 electron microscope with an
acceleration voltage of 80 kV, and electron micrographs were taken with
magnification factors between 85,000 and 140,000.
Results
SpecificityoftheAntibodies
For the location of the proteins A and 70K on the Ul snRNP
by immunoelectron microscopy, monoclonal IgG antibodies
against these proteins were used. The antibody specific for
the A protein (D5) has already been described in detail
by Reuter et al. (32) . On an immunoblot of Ul snRNP pro-
teins, it reacts with the A protein only, and it does not react
with protein-free Ul RNA (Fig. 1 A, lane 2) . In immuno-
blots of nuclear extracts and total snRNP proteins, antibody
D5 also reacts with protein B; which is present as a specific
protein in U2 snRNP (32). Since in this work purified Ul
snRNPs were used, the cross-reaction with B" has no sig-
nificance here.
The 70K-specific antibody Hlll was obtained by im-
munizing mice with purified HeLa snRNPs. When allowed
to react in immunoblot tests with mixtures ofUl snRNP pro-
teins, either total Ul protein (Fig. 1 A, lane 3) or proteins
from nuclear extracts (not shown), this antibody reacts with
the 70K protein only (7).
Chemical Cross-linkingofProteins Aand 70K
to UI snRNP
The electron-microscopic investigation and subsequentloca-
tion of the antibody-binding sites call for stable immune
complexes that withstand the purification steps and the prep-
aration for EM. A good measure of this is their stability dur-
ing gradient centrifugation, which was used for the separa-
tion of immunocomplexes from unbound antibodies and Ul
snRNPs (17) . However, first experiments with the anti-A and
anti-70K antibodies showed that none of the anti-A and at
most only a small proportion of the anti-70K immunocom-
plexes survived the centrifugation. Investigation of the gra-
dient fractions showed that it was not the antibody that dis-
sociated from the antigen, but rather the antigen (A or 70K
protein) that dissociated from the U1 snRNP after the anti-
body had been bound (data not shown) . In an attempt to pre-
840Figure 1. Protein analysis and
immunoblots of U1 snRNPs
using themAbsD5 (againstA
protein) and Hlll (against
70K) . (A) Immunoblots with
D5 and Hl 11 . Ul snRNPs pro-
teins were separated by SDS-
PAGE and immunoblotted
with the A-protein-specific
mAb D5 (lane 2) or the 70K-
protein-specific mAb Hlll
(lane 3) by the method of
Habets et al . (10) . The Coo-
massie-stained Ul snRNP
proteins are shown in lane 1 .
(B) SDS-PAGE ofUl snRNPs
cross-linked with DSP Pu-
rified Ul snRNPs were incu-
bated without DSP (lane 1),
or with DSP at a concentra-
tion of 20tM (lane 2), 60pM
(lane 3), or 180 pM (lane 4) .
The proteins were then ex-
tracted and separated by elec
trophoresis . Proteins were made visible by Coomassie staining . M, Proteinmolecular mass standards are in kilodaltons . (C) Protein compo-
sition of Ul snRNPs gradually depleted of proteins C, A, and 70K . Ul snRNPs containing their full set of specific proteins (lane 1), or
lacking the C protein (lane 2), both the C and the A proteins (lane 3), or all three specific proteins A, C, and 70K (lane 4) were ana-
lyzed by SDS-PAGE . The proteins were made visible by Coomassie staining . The Roman numerals refer to the corresponding panel
in Fig . 6 .
vent the loss of these two proteins from the RNP complex
during the experiment, they were cross-linked covalently to
the snRNP
For this purpose, Ul snRNPs were incubated with various
concentrations of the amino group-specific cross-linking re-
agent DSP, which possesses a cleavable disulphide bridge .
The subsequent protein analysis of the Ul snRNP showed a
decrease in intensity ofthe protein bands that increased with
the quantity of DSP used (Fig . 1 B) . At 180p.M DSP, the
cross-linking is so extensive thatprotein bands can no longer
be seen . The extended cross-linking presumably gives rise
to protein complexes with such high molecular weight that
they no longer can migrate into the gel (Fig . 1 B, lane 4) .
However, the chemical nature of the bound molecules does
not appear to change significantly, as shown by cleavage of
the cross-link with mercaptoethanol, after which the bands
of the Ul snRNP proteins again appear in their usual posi-
tion . Only the migration rate oftheD proteins retains a small
alteration (not shown) .
The reduction of the bands' intensity suggests that a
sufficient degree of cross-linking of proteins 70K and A to
the rest of the Ul snRNP is attained at a DSP concentration
of 60 p.M (Fig . 1 B, lane 3) . At this DSP concentration, the
immunoreactivity of the Ul snRNPs with the A- and 70K-
specific antibodies is only slightly reduced (analysis by
ELISA ; data not shown), and there is hardly any appearance
ofinterparticulate cross-linking (analysis by density gradient
centrifugation ; data not shown) ; for these reasons the risk of
artefacts of cross-linking may be neglected .
Ul snRNPs cross-linked with 60 p.M DSP were examined
under the electron microscope . Fig. 2 shows a selection of
negatively contrasted cross-linked Ul snRNPs . The size,
shape, and fine structure of these particles corresponded to
those of untreated Ul snRNPs (17) : globular main bodies,
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accumulation ofstain at the center, and shapes with two adja-
cent protuberances can be seen clearly. We conclude from
this that the introduction of the cross-linking reagent has not
led to any significant change in the shapes of the particles.
As previously discussed (17), the observed size variability of
the protuberances might be due to differences in the orienta-
tion of the particle upon absorption to the carbon film .
Labeling ofCross-linked UI snRNPs with
UIA-Protein-specific Antibodies
Ul snRNPs, cross-linked- at aDSP concentration of60pM,
were incubated with the antibody D5, which is specific for
A protein . The immunocomplexes formed were separated
from unbound Ul snRNPs and IgG molecules by gradient
centrifugation . Fractions from the gradient were then ana-
lyzed by microtitre ELISA for their content of Ul snRNPs
Figure 2 . EM of Ul snRNPs cross-linked withDSP and negatively
stained with uranyl formate . Selected micrographs ofUl snRNPs
cross-linked with 60 pM DSP are shown . The first row shows im-
ages with roughly symmetrical protuberances, and the second row
shows images in which one protuberance appears to predominate .
The micrographs are oriented so that the protuberances point up-
wards . Bar, 10 run .
84 1Figure 3 Immunocomplex formation monitored by density-gra-
dient centrifugation. Incubation mixtures of Ul snRNP prepara-
tions and the A-protein-specific (C-E) or the 70K-protein-specific
(F-H) antibody were centrifuged in a 6-20% sucrose gradient. The
gradients were separated in 120-pl fractions from the bottom up.
Direction of sedimentation was to the left. Aliquots of these frac-
tions were then tested by the ELISA method, either (a) for their
content of snRNP, with an and-RNP serum followed by secondary
antihuman antibody conjugated with alkaline phosphatase (solid
circles), or (b) for their content of mouse anti-m3G antibody with
an anti-(mouse IgG) antibody conjugated with phosphatase (open
circles). (First column) inA only DSPcross-linked UI snRNPs and
inB only IgG antibodies (DS) were loaded onto the gradient. These
therefore indicate the positions to which the isolated Ul snRNPs
and the IgG molecules sediment. (Second column) 1.3 wg of the
A-protein-specific antibody (DS) was incubated with 3 Fig of DSP
cross-linked Ul snRNPs (C), non-cross-linked Ul snRNPs (D) or
DSPcross-linked A[C,A]-Ul snRNPs (E), which lack the proteins
C and A. (Third column) 1.6 Ag of the 70K-protein-specific anti-
body (HIII) was incubated with 3 jug of DSPcross-linked (F) or
non-cross-linked (G and H) Ul snRNPs before centrifugation. In
H, the HI 11 antibody was first incubated with 0.3 iug of fusion pro-
tein pEE71 before UI snRNPs were added. This protein contains
the NHZ-terminal domain of the 70K protein fused to 0-galac-
tosidase. In this experiment, quantification of the Ul snRNP was
not possible by the ELISA method used because ofthe strong cross-
reaction of the anti-RNP serum used for detection of the UI snRNPs
with the fusion protein.
and IgG antibodies. In Fig. 3 (A and B), the sedimentation
behavior of free Ul snRNPs and IgG antibodies in a 6-20%
sucrose gradient is shown. The snRNPs (fractions 5 and 6)
sedimented,one to two fractions ahead ofthe IgG molecules
(fraction 7).
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Fig. 3 C shows the distribution of snRNPs and antibodies
in the fractions after centrifugation ofthe incubation mixture
ofcross-linked Ul snRNPs with the A-protein-specific anti-
body D5. A shift ofboth the Ul snRNPs and the anti-A anti-
bodies towards higher S values is seen clearly. This shows
that most ofthe cross-linked Ul snRNPs and anti-A antibod-
ies sediment as immunocomplexes. The cross-linking of the
A protein to the rest ofthe snRNP thus overcame the prob-
lem of the instability of the immunocomplexes.
If the Ul snRNPs had not been pretreated by DSP cross-
linking, stable immunocomplexes were not observed (Fig. 3
D). The slight shift of the Ul snRNPs and the antibodies to-
ward higher S values suggests that immunocomplexes were
formed in the incubation but dissociated during the centrifu-
gation. That the immunocomplex formation in the caseofthe
cross-linked Ul snRNPs indeed took place via the binding
ofthe D5 antibody to the A protein was concluded from the
following experiment. The A-protein-specific antibody D5
was incubated, under the same conditions as before, with
cross-linked Ul snRNPs that lack the proteins C and A
(A[C,A]-Ul snRNPs ; see Materials and Methods) . No im-
munocomplexes were observed on the density gradient (Fig.
3 E). The absence of the C protein was not responsible for
the failure to react with anti-A antibodies, as the D5 antibod-
ies showed just as little reactivity in an ELISA assay with Ul
snRNPs that lack protein A only as they do with Ul snRNPs
that lack both A and C ; however, it reacted with complete
particles, i.e., particles that contain A protein (data not
shown).
For EM of immunocomplexes between antiA antibody
and cross-linked Ul snRNPs, negatively contrasted prepara-
tions of fraction 4 from the gradient centrifugation (Fig. 3
C) were made. Fig. 4 A shows a general view of these im-
munocomplexes, in which free antibodies, free Ul snRNPs
and Ul snRNPimmunocomplexes can all be recognized. In
all the immunocomplexes, the antibody is seen bound to a
protuberance of the Ul snRNP Fig. 4 B shows a selection
of typical immunocomplexes at higher magnification. In the
143 immunocomplexes examined in detail, about one-halfof
the Ul snRNPs appeared in a projection that allowed two
protuberances to be recognized clearly (Fig. 4 B). The
majority of the remaining immunocomplexes allowed only
one protuberance to be recognized. The antibody-binding
site was always located on a protuberance. The simultaneous
binding of two antibodies, one at each protuberance, or two
at one protuberance, was never observed.
Labeling of Cross-linked UI snRNPs with
719K-Protein-specific Antibodies
Ul snRNPs cross-linked with 60 p.M DSP were incubated
together with the 70K-protein-specific antibody H111 and
centrifuged in a sucrose gradient. The fractions were then
analyzed by microtitre-ELISA for their content of Ul snRNP
and IgG antibodies. Fig. 3 F shows the result: Almost the en-
tire antibody population sedimented considerably more rap-
idly than free antibodies (compare Fig. 3 B) . The antibodies
also sedimented more rapidly than free Ul snRNPs. This
is a clear indication that stable immunocomplexes were
formed.
Non-cross-linked Ul snRNPs also formed immunocom-
plexes with the 70K-specific antibody H111. However, in this
case the yield was lower; only a small number ofthe antibod-
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fraction number EFigure 4. The binding of antibody against protein A to U1 snRNPs . (A) General view of the sucrose gradient fraction containing im-
munocomplexes formed by incubation of DSPcross-linked Ul snRNPs with the A-protein-specific mAb D5. Arrowheads point to the
antibody-binding sites . (B) Gallery of selected Ul-(anti-A IgG) immunocomplexes. The Ul snRNPs in the complexes are oriented with
the protuberances pointing upwards. The complex at the far right of each row is illustrated by an interpretative sketch . The stippled area
marks the antibody. Bars, 10 nm .
ies appeared in the immunocomplex fraction (Fig . 3 G) in
comparison with the experiment using cross-linked Ul
snRNPs. If the Hll l antibody is preincubated with the ß-gal
fusion protein pEE71, which carries the H111-reactive epi-
tope (see Materials and Methods), the immunocomplex peak
disappears completely (Fig . 3 H) . This shows that the Hlll-
antibody also recognizes the70K protein in the intact parti-
cle . In agreement with this is the further observation that
A[C,A,70K]-Ul snRNPs, which lack not only proteins A
and C but also 70K (see below), likewise fail to form im-
munocomplexes (data not shown) .
For the electron microscopic location of the binding sites
for antibodies, immunocomplexes ofthe anti-70K antibodies
with cross-linked Ul snRNPs (see above) were investigated .
After the centrifugation, on a gradient like that in Fig . 3 F,
negatively contrasted preparations were made from fraction
4 . Fig. 5 A shows a general view in which a number of im-
munocomplexes can be recognized . Again, without excep-
tion, the antibody-binding sites are all located on one of the
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protuberances . Fig . 5 B shows a selection of typical im-
munocomplexes at higher magnification . In the first three
rows, both protuberances can be seen on the labeled Ul
snRNP ; this was the case for more than halfofthe 149 com-
plexes examined in detail . The antibody always binds to one
of the protuberances . The simultaneous binding of two anti-
bodies, to both protuberances, or to one protuberance, was
never observed .
The results ofthe two experiments involving labeling ofUl
snRNPs with the antibodies against theA and 70K proteins
showed that both the A and the 70K proteins are located in
the Ul snRNP protuberances (Figs . 4 and 5) . However, such
experiments cannot reveal whether these proteins lie to-
gether in the same or in two separate protuberances. It also
remains an open question whether the existence of the pro-
tuberances is attributable solely to the presence ofthese pro-
teins . To study these questions, we investigated the shapes
of protein-deficient Ul snRNPs under the electron micro-
scope.
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Figure S. The binding of anti-
body against 70K protein to
Ul snRNPs . (A) General view
of a sucrose gradient fraction
containing immunocomplexes
formed by incubation ofDSP
cross-linked Ul snRNPs with
the 70K-specificmAb D5 . Ar-
rowheads point to the anti-
body-binding sites . (B) Gal-
lery of selected Ul-(anti-70K
IgG) immunocomplexes . The
Ul snRNPs in the complexes
are oriented with the pro-
tuberances pointing upwards.
The complex at the far right
of each row is illustrated by
an interpretative sketch . The
stippled area marks the anti-
body. Bars, 10 nm .Figure 6 . U1 snRNPs gradu-
ally depleted of their specific
proteins . General views of
negatively stained prepara-
tions (A) and selected images
(B) of complete (I) and Ul
snRNPs lacking protein C
(II), both proteins C and A
(III), or all three specific pro-
teins C, A, and 70K (IV) . In
A protuberances are labeled
with triangles. Bar, 20 nm . In
B images are selected which
show a high degree of struc-
tural similarity even if pro-
tuberances are missing .EM ofProtein-depleted 19 snRNPs
It has recently been shown that Ul snRNPs can be depleted
gradually of their specific proteins C, A, and 70K by ion-
exchange chromatography using Mono Q columns at ele-
vated temperatures (1). With this method, U1 snRNPs selec-
tively depleted of protein C (AC-Ul), protein A (AA-Ul),
both proteins C and A (0[C,A]-Ul), or of all three Ul-
specific proteins, C, A, and 70K (A[C,A,70K]-Ul) can be
isolated. The three Ul-snRNP species A[C], A[C,A], and
A[C,A,70K] (see Fig. 1 C for protein analysis) were purified
in sufficientamounts to study theirmorphologyby EM. Fig.
6 A shows general views of negatively stained preparations
of each of the protein-deficient Ul snRNPs and, as well,
complete Ul snRNPs containing the full set of particle-
specific proteins. In all four preparations, the images contain
a globular structure ti8 nm in diameter, similar to the main
body described previously (17, 18). But there are substantial
differences in the appearance ofthe protuberances in the im-
ages of the protein-depleted Ul snRNPs. In the preparation
of the A[C]-Ul snRNPs (Fig. 6 11), the two protuberances
can be seen clearly (marked with double arrows in Fig. 6),
and they appear with about the same frequency as they do
in the complete Ul snRNP (see Table 1) . Furthermore, the
images with only one recognizable protuberance (marked by
single arrows in Fig. 6) are present in the same proportion
as in the control (Table I). The A[C,A]-Ul snRNPs also show
images with one protuberance, but images with two pro-
tuberancescan only be seen very rarely (Fig. 6 111 and Table
I) . Images of the A[C,A,70K]-Ul snRNPs, which lack all
specific Ul snRNP proteins, containing only the set ofcom-
mon proteins (Fig. 1 C), show virtually nothing but the
structure of the globular body; protuberances are hardly
visible in these images (Fig. 6 IV, Table I). These experi-
ments demonstrate that the removal of the A protein results
in the loss of one protuberance and removal ofthe 70K pro-
tein results in the loss of the other protuberance.
Next we compared representative images selected for a
high degree of structural similarity. This was done for each
preparation in turn. Typical forms of complete Ul snRNPs
(17) were taken as reference and typical images of the
protein-deficient particles were selected for forms that ap-
peared similar (except, of course, in respect of the lack of
protuberances in A[C,A]-Ul and A[C,A,70K]-Ul snRNPs) .
As an example, images similar to the roughly symmetrical
Ul snRNP-form are shown in Fig. 6 B. Images of the A[C]-
U1 snRNP particles could be found showing all the typical
features of the reference forms. Both the body and the two
protuberances appear similar to the corresponding features
in the Ul snRNP reference form. Within the resolution ofthe
electron micrographs (N2 nm) no systematic differences be-
tween the complete particle and the particle deficient in C
protein couldbe observed. Comparison of typical images of
the A[C,A]-Ul snRNP with the reference forms showed no
structural change beyond the lack of the one protuberance.
Comparison of the core RNP structure of A[C,A,70K]-Ul
snRNPs with that of the other two Ul snRNP species reveals
a high structural similarity between the snRNP bodies ofthe
complete and the depleted particles.
We conclude from these experiments that one protuber-
ance ofthe Ul snRNP does indeed contain the A protein and
the other the 70K protein. The binding of each of these pro-
teins to the snRNP seems to be sufficient to generate the
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Table I. Number ofProtuberances Visible on Images of UI
snRNPParticles Lacking Specific Proteins
* Structures protruding more than 2 run from the main body of the particle
were counted as protuberances. Images with smooth, approximately roundout-
lines are counted as showing no protuberances. If the outline appeared irregu-
lar or could not be traced unambiguously, the image was denoted X.
structural appearance of the respective protuberance. The
location of the C protein could not be determined by visual
comparison of negatively stained images of complete Ul
snRNPs with those lacking this protein. The failure to detect
morphological differences couldbe due to dissociation ofthe
C protein during sample preparation for EM. To investigate
this possibility we compared A[C]-Ul snRNPs with cross-
linked Ul snRNPs which not only have the 70K and the A
proteins efficiently covalently linked (see above), but also the
C protein (Fig. 1 B). However, no morphological difference
could be detected (data not shown), confirming that the
removal ofthe C protein does not result in a detectable struc-
tural change in the Ul snRNP particle.
We also compared the morphology of cross-linked and
non-cross-linked complete Ul snRNPs. Although qualita-
tively there were no detectable differences, particles possess-
ing two protuberances were observed with greater frequency
with the cross-linked Ul snRNPs (Table I) . This indicates
that during sample preparation for EM proteins can dissoci-
ate from the Ul snRNP As shown previously by antibody
labeling experiments, the relatively weak association of the
A protein in particular might be responsible for the less fre-
quentappearance ofthe two protuberances in the absence of
covalent cross-linking.
Positions ofthe A and 70K Protuberances Relative to
the Site ofthe m3G Cap
In previous work, we located the m3G 5'-end of the Ul
RNA on the main body of the Ul snRNP, by labeling the
m3G base with m3G-specific antibodies (17). This site was
found to be clearly separated from the base of the two pro-
tuberances. To investigate the positions of the protuberances
with respect to the cap site, we conducted experiments that
allowed simultaneously both the location of the cap site and
the assignment of the protuberances. To label the cap site,
we used the m3G-specific monoclonal antibody H2O em-
ployed previously (17) .
First, we investigated the distance of the cap site from the
70K protuberance. Assignment ofthe 70K protuberance was
made possible by using A[C,A]-Ul snRNPs. These particles
lack the A protein and therefore have only one protuberance,
the one associated with the 70K protein. The m3G-specific
mAb H2O was incubated with A[C,A]-Ul snRNPs, and frac-
tions containing the immunocomplex were obtained by gra-
dient centrifugation. Electron micrographs were taken from
negatively stained samples. Fig. 7 A shows a general view
and Fig. 7 B a gallery of selected typical complexes. In all
cases, the anti-m3G antibody binds to the main body of the
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Number of
protuberances
visible* Complete AC
U1 snRNP
A(C,A)
particles
A(C,A,70K) Cross-linked
2 35 31 4 2 44
1 28 29 31 7 16
0 7 6 15 48 8
X 30 34 50 43 27Figure 7 . The binding of antibody againstm3G to Ul snRNPs lack-
ing both proteinsC and A . (A) General view of a gradient fraction
containing immunocomplexes formed by incubation of A[C,A]-Ul
snRNPs with the m3G-specificmAb H20. Arrowheads point to the
antibody-binding sites . (B) Gallery of selected [A[C,A]-Ul-anti-
m3G IgG] and [A[C,A]-Ul-and-m3G IgG A[C,A]-Ul] complexes .
The complex at thebottom of each columnis illustrated by aninter-
pretative sketch . The stippled area marks the antibody. Bar, 10nm .
Ul snRNP at a site relatively close to the 70K protuberance .
Antibody-binding sites directly opposite the base of the pro-
tuberance were not observed . This suggests thatthe 70K pro-
tuberance is located close to the m3G cap.
In the second experiment, we attempted to investigate the
distance of the cap site from the A protuberance . Unfortu-
nately, Ul snRNPs lacking the 70K protein but containing
the A protein, so that only the A protuberance is present,
have not yet been observed . We therefore pursued a more
complex strategy involving antibody double labeling, in or-
der to discriminate between the two protuberances . Com-
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plete Ul snRNPs were labeled with two antibodies simul-
taneously : the anti-m3G antibody to mark the cap site and
the anti-A antibody to label the protuberance containing A
protein . Ul snRNPs cross-linked with DSP were incubated
with both antibodies and, after gradient centrifugation, frac-
tions containing immunocomplexes were examined under
the electron microscope. Fig. 8A shows an overview ofparti-
cles fromthe fraction in which the greatest number ofdoubly
labeled Ul snRNPs was found . Alongside [Ul-IgG] com-
plexes, free IgG molecules and Ul snRNPs, five [IgG-Ul-
IgG-Ul] complexes can be seen .
Several electron micrographs were searched for such im-
munocomplexes containing at least two antibodies . In most
complexes, the typical Ul snRNP and IgG structures can
hardly be recognized . Nevertheless, 11 doubly labeled Ul
snRNP complexes could be recognized where the antibody-
binding sites were found at opposite sites of the Ul snRNP
Fig . 8 B shows some examples at higher magnification .
Large distances between the m3G-cap site and the A pro-
tuberance are seen, showing that these two sites are well
separated in the Ul snRNP particle .
Similar experiments involving double labeling with the
anti-m3G-cap antibody and the anti-70K antibody were also
performed . However, here we have so far been unable to de-
tect immunocomplexes for which the Ul snRNP and the two
bound antibodies could all be seen clearly. This inability
could be the consequence ofa relatively close location of the
two antibody binding sites, because the closer the two bound
antibodies are, the more difficult is an unambiguous recogni-
tion of these antibodies .
Discussion
In this work, we have used electron microscopic techniques
to investigate the distribution of the proteins in the Ul
snRNP particle . Two strategies were used to locate the pro-
teins : (a) successive removal of Ul-specific proteins and (b)
labeling with monoclonal IgG antibodies .
Complete Ul snRNPs consist of two types of domain : a
globular main body and two protuberances that originate
from adjacent sites on the main body. The removal of all
three specific proteins, 70K, A, and C, from the Ul snRNP
leaves behind a globular structure N8 run in diameter. As
shown by gel electrophoresis, all the common proteins are
contained in this coreRNP The core is very similar in shape
to the main body of the complete Ul snRNP particle (see
Fig. 6 B) . It is therefore highly probable that all thecommon
proteins are located in the body . This is in agreement with
the results of previous studies of snRNPs U2, U5, and
U4/U6 ; in each of these, a globular structure very similar
in size, shape, and fine structure to the main body of Ul
snRNP was observed and was found to contain all the com-
mon proteins (18, 19) . These results suggest that the two
characteristic protuberances of Ul snRNPmay represent the
Ul-specific proteins, an idea confirmed in this work both by
successive removal of the Ul-specific proteins and by label-
ing with antibodies . While loss of protein C alone did not
change to a significant extent the appearance ofthe Ul RNP
as compared with the complete particle, the loss of protein
A in addition to protein C resulted in the disappearance of
one of the typical protuberances of Ul snRNP This implies
thatone protuberance ofthe Ul RNPmay consist principally
sahFigure 8. Simultaneous binding of the antibodies against A protein
and the m3G cap to DSP-cross-linked Ul snRNPs . (A) General
view of a gradient fraction containing double antibody-labeled Ul
snRNPs . The arrowhead points to the antibody-binding sites at the
doubly labeled Ul snRNPs . (B) Selected complexes showing dou-
ble antibody-labeled Ul snRNPs . An interpretative sketch is shown
at the right of each complex . The stippled area marks the antibody.
Bar, 20nm . (C) Locations ofproteinsA and 70K and them3G cap
at the Ul snRNP In the interpretative drawing, the round core do-
main is indicated (dotted line), and the locations ofthe specific pro-
teins A and 70K (stippled area) and the m3G cap site at the 5' end
ofthe Ul snRNPs (hatchedarea) are shown . (D) Tentative location
of the Ul RNA at the Ul snRNP . The 5'-terminal cap and
stem/loops I and II are located according to the localization ofthe
m3G cap, the 70K, and the A protein, respectively . The locations
of stem/loop III and the domain A are arbitrary.
oftheA protein and the other of the70K protein . The distri-
bution of these two proteins in the two protuberances was
confirmed by our finding thatmAbs against the 70K protein
or the A protein each bound only to one of the protuber-
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ances . No immunocomplexes were seen in which one kind
ofmAb had reacted with both protuberances . The molecular
masses of the two proteins deduced from their sequences are
52 kD for the 70K and 32 kD for the A protein (29, 39, 40,
44) . If a specific volume of 0.73 cm3 g- ' and a spherical
form are assumed, the calculated diameters are 4.9 nm
(70K) and 4.2 run (A) . These correspond reasonably well
with the observed shapes ofthe two protuberances, -3-4 run
in width and 4-7 nm in length, the estimate varying some-
what with the orientation of the Ul RNP particle on the grid .
Because of the symmetric appearance ofthe two protuber-
ances in most of the electron micrographs of Ul RNPs, it is
not possible to see directly which protuberance is associated
with 70K and which with A . We therefore attempted to
define the positions of the two protuberances with respect to
a third topological site on the surface of Ul snRNP, namely,
the 5'-terminal m3G cap structure of the snRNA. For this
purpose, we conducted two series ofexperiments based upon
our earlier observation that them3G cap structure is located
on the main body of the Ul snRNP close to one ofthe pro-
tuberances (17) . First, we labeled Ul snRNP particles with
an anti-m 3G antibody and, at the same time, with a mAb
specific for the A protein . Secondly, we labeled Ul snRNP
that lacked the A and C proteins (i.e ., particles containing
only the 70K protuberance) with antibodies against the
m3G cap . The results of both studies suggest that the m 3G
cap is closer to the70K protuberance than to the A protuber-
ance. Fig . 8 C shows a two-dimensional model of the Ul
snRNP summarizing these data .
The observation of two distinct locations for proteins 70K
and A in the two protuberances also agrees well with data
from studies ofbinding between the two free proteins and the
isolated stem/loops I and II from U1 snRNA : protein 70K
binds to stem/loop I but not to II, and protein A binds to
stem/loop II but not to I (22, 30, 34, 35, 42) . However, the
binding of protein 70K to complete Ul RNA is not always
completely independent of the binding ofprotein A, because
in Xenopus a direct or indirect mutual stimulation of binding
of these two proteins has been observed (13, 14) . In our
model, the bases of the two protuberances lie close to one
another, so that proteins 70K and A could be in contact,
which would explain the observed cooperativity of their
binding .
The location of proteins 70K and A in the protuberances
reveals indirectly the positions ofstem/loops I and II . Ifthese
sequences are involved in binding proteins70K andA to the
Ul snRNP, then each must lie at the base of its respective
protuberance. In Fig . 8 D, a possible localization of the Ul
RNA is shown in the Ul snRNP model . The localization of
stem/loop I and II, as well as the 5' terminus, can be deter-
mined by our electron microscopic data, while stem/loop In
and the domain A, including the 3'-terminal stem/loop, can
only be positioned arbitrarily. However, domainA should be
located in the core body, since it is the binding site ofthe core
proteins .
As discussed above, we were not able to locate protein C
by selective removal ofthis protein from Ul snRNPs, because
nomorphological changeswere seen when normal Ul snRNPs
were compared with Ul snRNPs depleted of this protein .
Furthermore, attempts to locate protein C directly by using
currently available anti-C antibodies also failed, probably
because of the low affinity of these antibodies towards this
847protein. For these reasons, only a tentative location can be
made, on the basis of circumstantial evidence from the re-
quirements for the binding of protein C. The fact that Ul
snRNPparticles canbe isolated that lack only protein A indi-
cates that protein A probably plays only a minor role in bind-
ing protein C. This is supported by assembly experiments
with mutated Ul RNA, where the incorporation ofboth 70K
and C was affected by the same set of mutations (12) and by
our finding that it is possible to incorporate protein C, trans-
lated in vitro, into A[C,A]-Ul particles (26). These results,
along with the finding that protein C does not bind to naked
Ul RNA, suggest that the 70K protein may be a part of the
binding site of protein C. However, in human Ul snRNPs
protein C can be cross-linked to the 70K and A proteins (4,
15), suggesting that protein C is in close proximity to the
other two. These data are consistent with our two-
dimensional model of Ul RNP if the binding site for the C
protein is close to the bases ofthe two protuberances on the
core RNP body. Such a location would also explain our fail-
ure to observe a structural change upon protein C removal.
That is, depletion of a spherical protein with a diameter of
3.4 run (the value calculated for protein C when it has a mo-
lecular mass of 17.4 kD [26]) from the bulky core body
should be much more difficult to detect than deletion from
an exposed structure like the protuberance.
We showed previously that protein C strengthened
significantly the binding of a 5' splice site RNA to the 5' end
of Ul RNA, while the presence or absence of protein A at
the Ul RNP particle showed only marginal effects (16).
These data are in good agreement with the Ul RNP model
discussed above, where proteins 70K and C are positioned
close to the 5' end of Ul RNA and protein A is furthest away
from this site. The exposed positions of protein A and part
of protein 70K suggest that these two proteins couldprovide
interaction sites with other components of the spliceosome.
The distribution of the common and the specific Ul
snRNP proteins may also be of importance in connection
with certain autoimmune diseases. As described in the In-
troduction, SLE and MCTD patients both produce antibod-
ies against Ul snRNPs, but with the important difference that
SLE patients have antibodies against the common proteins
(anti-Sm), whileMCTD patients have antibodies against the
specific proteins of Ul snRNP (anti-RNP) (43). It is not
known why the immune system responds in these two distinct
ways to the Ul snRNP particle as an antigen. Since snRNP-
specific autoantibodies can be induced experimentally by
immunization with snRNPs (31), it is probable that the
pathological immune response is also induced directly by Ul
snRNPs. It follows that the cause of the different autoanti-
body specificities in SLE and MCTD patients may reside in
the structure of the snRNPs. In support of this hypothesis,
the work described in this paper has shown that the two sets
of epitopes are located in different places on the Ul snRNP
particle: SLE autoantibodies are directed against the round,
compact main body and MCTD autoantibodies against the
exposed proteins of the protuberances. The physical group-
ing of the epitopes could result in the one or the other set
being presented to the immune system, and it may thus pro-
vide a physical basis for the specificity of the autoimmune
response.
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